NGS & Microbiome Analytics for Biomarkers, Safety and QC

BIOMNIGENE provides end-to-end NGS-based analytical services and advanced bioinformatics to accelerate biotech R&D and enable robust manufacturing control & quality control (QC). We support innovation projects at the intersection of biotech and enabling technologies, delivering actionable data for biomarker discovery, product efficacy monitoring, safety assessment, traceability, and decision-making.

What we do

• Microbiome & metagenomics: 16S/ITS/18S and shotgun metagenomics (study design, sampling strategy, sequencing, interpretation)

• Bioinformatics & digitalisation: standardized pipelines, metadata integration, reproducible reporting, dashboards-ready outputs

• Biomarkers & translational R&D: cohort studies, stratification signals, longitudinal monitoring, endpoints support

• Safety & quality: detection/monitoring of microbial risks (contaminants, unwanted organisms), batch-to-batch consistency insights, traceability/authenticity signals

• Molecular assays & orthogonal confirmation (when relevant): targeted qPCR/dPCR panels to complement NGS findings

Typical use cases

• R&D teams needing robust, transferable biomarkers from complex biological data

• Industrial biotech & manufacturing teams strengthening QC programs with NGS-based evidence

• Digital health / diagnostics innovation requiring clean, structured datasets and reproducible analytics

• Consortia looking for an experienced partner to build international collaborative projects (Eureka/Horizon Europe/partner searches via EEN)

What partners get

• A reliable partner combining wet lab + bioinformatics

• Clear deliverables: project-ready reports, standardized data formats, and interpretation tailored to stakeholders (R&D, QA/QC, regulatory, business)